Skip to main content

Table 1 Clinical parameters between smokers and non-smokers at baseline (before cessation of smoking)

From: Long term effects of smoking cessation in hospitalized schizophrenia patients

  Smokers Non-smokers P value
Number 38 32  
Sex 7/31 11/21  
Age (years) 57.9 ± 12.5 54.3 ± 13.6 0.241
Duration of illness 33.2 ± 14.5 32.7 ± 13.5 0.876
ln total1 4.5 ± 1.2 3.9 ± 1.2 0.071
ln LF1 3.8 ± 1.3 3.2 ± 1.4 0.163
ln HF1 3.8 ± 1.2 3.1 ± 1.3 0.016*
BMI (kg/m2) 22.7 ± 4.0 21.7 ± 4.0 0.276
ALB (g/dL) 4.0 ± 0.3 4.0 ± 0.4 0.204
BS (mg/dL) 89.7 ± 17.4 87.5 ± 15.5 0.655
LDL-C (mg/dL) 119.0 ± 33.2 108.4 ± 29.6 0.163
TC (mg/dL) 200.4 ± 42.2 183.9 ± 32.0 0.065
TG (mg/dL) 118.9 ± 91.1 86.0 ± 43.2 0.073
HDL-C (mg/dL) 60.4 ± 16.6 55.9 ± 13.2 0.222
CPZeq*2 (mg) 1229 ± 750 1162 ± 792 0.717
BPDeq*2 (mg) 2.9 ± 1.9 1.6 ± 1.6 0.003*
DZPeq*2 (mg) 10.1 ± 6.9 9.3 ± 7.4 0.653
GAF score 28.9 ± 3.1 29.2 ± 2.2 0.682
  1. Data are presented as means ± standard deviation
  2. *Significant difference (p < 0.05)
  3. 1Logarithmic conversion was performed
  4. 2Daily dose of antipsychotic was converted to the approximate respective equivalent dose
  5. LF Low Frequency, HF High frequency, BMI Body mass index, ALB Serum albumin, BS Blood sugar, LDL-C Low-density lipoprotein cholesterol, TC Total cholesterol, TG Triglycerides, HDL-C High-density lipoprotein cholesterol, CPZeq Equivalent conversions of chlorpromazine, BDPeq Equivalent conversions of biperiden, DZP Equivalent conversions of diazepam, GAF Global Assessment of Functioning